Europe Nerve Repair & Regeneration Market by Types (Neurostimulation, Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), Procedures (Direct Nerve Repair, Nerve Grafting, Neuromodulation Surgery, Stem Cell Therapy) - Forecast to 2019

The nerve repair and regeneration market in Europe has displayed significant growth at a CAGR of 11.9%. Germany garnered the maximum market share and is expected to grow at a CAGR of 11.1%, followed by France and the U.K. There have been a whole lot of challenges for the market, such as research expenditure, along with the lack of availability and awareness of neurosurgeons. Despite these restraints, this market has shown significant growth. The market has been divided into nerve repair by biomaterials and nerve repair by neurostimulation, where the repair by neurostimulation segment has the highest market share and nerve repair by neurostimulation displays a comparatively high growth rate among the other two markets.

There have been numerous opportunities for the market to grow, such as acquisitions between the top players to increase the technical efficiency of the procedures and to deliver good results in the market; Stryker (U.S.) acquired the assets of CHG beds Inc. (London) that is oriented towards enhancing the quality of services provided by Stryker. Similarly, there has been a huge collaboration among various players to share their technologies and contribute to the market growth. Also, the number of surgeries and health care expenditure is increasing at an individual level that would stimulate the growth of the market. 

Yet, the overall market growth has been positive and is continued to remain so by 2019. Also, there have been a whole lot of market developments with regards to the devices.

The report shares a competitive view of various companies in the markets in terms of the regions they operate in, along with the revenue bifurcation and market share value of each of them. The report provides a brief insight about the kind of market it is in and confirms the comparative growth for the neurology device market.

The key market players that have been listed in this report are Integra life sciences Corporation, Stryker, Medtronic Inc., etc. The report also provides a detailed analysis of a number of units by install base and what they are projected to grow to.

Table of Contents

1 Introduction (Page No. - 8)
    1.1 Objectives of the Study
    1.2 Market Segmentation & Coverage
    1.3 Stakeholders
2 Research Methodology (Page No. - 10)
    2.1 Integrated Ecosystem of Nerve Repair and Regeneration Market
    2.2 Arriving at the Nerve Repair and Regeneration Market Size
           2.2.1 Top-Down Approach
           2.2.2 Bottom-Up Approach
           2.2.3 Macro Indicator-Based Approach
    2.3 Assumptions
3 Executive Summary (Page No. - 17)
4 Market Overview (Page No. - 18)
    4.1 Introduction
    4.2 Nerve Repair and Regeneration Market : Comparison With Parent Market
    4.3 Market Drivers and Inhibitors
    4.4 Key Market Dynamics
5 Nerve Repair and Regeneration Market, By Type (Page No. - 29)
    5.1 Introduction
    5.2 Nerve Repair and Regeneration Market, Type Comparison With Neurology Devices Market
    5.3 Europe Nerve Repair By Biomaterials , By Geography
    5.4 Europe Nerve Repair By Neurostimulation , By Geography
6 Nerve Repair and Regeneration Market, By Geography (Page No. - 37)
    6.1 Introduction
    6.2 German Nerve Repair and Regeneration Market
           6.2.1 German Nerve Repair and Regeneration Market, By Type
    6.3 France  Nerve Repair and Regeneration Market
           6.3.1 France Nerve Repair and Regeneration  Market, By Type
    6.4 UK Nerve Repair and Regeneration Market
           6.4.1 UK Nerve Repair and Regeneration Market, By Type
    6.5 Italy  Nerve Repair and Regeneration Market
           6.5.1 Italy Nerve Repair and Regeneration Market, By Type
    6.6 Spain Nerve Repair and Regeneration Market
           6.6.1 Spain Nerve Repair and Regeneration Market, By Type
    6.7 ROE Nerve Repair and Regeneration Market
           6.7.1 ROE Nerve Repair and Regeneration Market, By Type
7 Nerve Repair and Regenartation Market: Competitive Landscape (Page No. - 56)
    7.1 7 Nerve Repair and Regenartation Market: Company Share Analysis
    7.2 Mergers & Acquisitions
    7.3 Expansions
8 Nerve Repair and Regeneration Market, By Company (Page No. - 60)
    8.1 Integra Lifesciences Holdings Corp.
           8.1.1 Overview
           8.1.2 Key Financials
           8.1.3 Product and Service Offerings
           8.1.4 Related Developments
    8.2 Axogen, Inc.
           8.2.1 Overview
           8.2.2 Key Operations Data
           8.2.3 Product and Service Offerings
           8.2.4 Related Developments
    8.3 Polyganics.
           8.3.1 Overview
           8.3.2 Key Operations Data
           8.3.3 Product and Service Offerings
           8.3.4 Related Developments
    8.4 Stryker Corporation
           8.4.1 Overview
           8.4.2 Key Financials
           8.4.3 Product and Service Offerings
           8.4.4 Related Developments
    8.5 S.T Jude Medical
           8.5.1 Overview
           8.5.2 Key Financials
           8.5.3 Product and Service Offerings
           8.5.4 Related Developments
    8.6 Medtronic, Inc.
           8.6.1 Overview
           8.6.2 Key Financials
           8.6.3 Product and Service Offerings
           8.6.4 Related Developments
9 Appendix (Page No. - 77)
    9.1 Customization Options
           9.1.1 Technical Analysis
           9.1.2 Low-Cost Sourcing Locations
           9.1.3 Regulatory Framework
           9.1.4 Impact Analysis
           9.1.5 Trade Analysis
           9.1.6 Historical Data and Trends
    9.2 Related Reports
    9.3 Introducing RT: Real Time Market Intelligence
           9.3.1 RT Snapshots

List of Tables

Table 1 Europe Nerve Repair and Regeneration Market: Macro Indicators,  By Geography, 2014 (Hce)
Table 2 Nerve Repair and Regeneration  : Comparison  With Parent Market, 2013 – 2019 (USD MN)
Table 3 Europe Nerve Repair and Regeneration  Market: Drivers and Inhibitors
Table 4 European Nerve Repair and Regeneration Market, By Type,  2013 – 2019 (USD MN)
Table 5 European Nerve Repair and Regeneration Market, By Geography ,  2013 - 2019 (USD Million)
Table 6 Europe Nerve Repair and Regeneration Market, By Type,  2012 - 2018 (USD MN)
Table 7 Europe Nerve Repair and Regeneration  Market: Type Comparison With Parent Market, 2013–2019 (USD MN)
Table 8 Europe Nerve Repair By Biomaterials Market, By Geography,  2012–2018 (USD MN)
Table 9 Europe Nerve Repair By Neuirostimulation    , By Geography,  2013 - 2019 (USD MN)
Table 10 Europe Nerve Reppair and Regeneration  Market, By Geography,  2012 - 2018 (USD MN)
Table 11 German Nerve Repair and Regeneration Market, By Type, 2012 - 2018 (USD MN)
Table 12 France Nerve Repair and Regeneration  Market, By Type, 2013 - 2019(USD MN)
Table 13 UK Nerve Repair and Regeneration : Market, By Type, 2012 - 2018 (USD MN)
Table 14 Italy Nerve Repair and Regeneration : Market, By Type, 2013 - 2019 (USD MN)
Table 15 Spain Nerve Repair and Regeneration : Market, By Type, 2013 - 2019 (USD MN)
Table 16 ROE  Nerve Repair and Regeneration : Market, By Type, 2013 - 2019 (USD MN)
Table 17 Nerve Repair and Regeneration Market: Company Share Analysis, 2013 (%)
Table 18 Europe Nerve Repair and Regeneration Market: Mergers & Acquisitions
Table 19 Europe Nerverepair and Regeneration  Market: Expansions
Table 20 Europe Nerverepair and Regeneration  Market: Investments
Table 21 Integra Lifesciences Holdings Corp, Inc.: Key Financials, 2008 - 2013 (USD MN)
Table 22 Axogen, Inc.: Key Operations Data, 2009 - 2013 (USD MN)
Table 23 Stryker Corporation Asa: Key Financials, 2009 - 2013 (USD MN)
Table 24 S.T Jude Medical : Key Financials, 2009 - 2013 (USD MN)
Table 25 Medtronic , Inc : Key Financials, 2009 - 2013 (USD MN)
 
List of Figures

Figure 1 North America Nerve Repair and Regeneration Market: Segmentation & Coverage
Figure 2 Nerve Repair and Regeneration Market: Integrated Ecosystem
Figure 3 Research Methodology
Figure 4 Top-Down Approach
Figure 5 Bottom-Up Approach
Figure 6 Macro Indicator-Based Approach
Figure 7 Europe Nerve Repair and Regeneration Market Snapshot
Figure 8 European Nerve Repair and Regeneration  Types, By Geography,  2013 (USD MN)
Figure 9 Europe Nerve Repair and Regeneration  Market, By Type, 2012 - 2018 (USD MN)
Figure 10 Europe Nerve Repair and Regeneration  Market: Type Comparison With Neurology Devices , 2013–2019 (USD MN)
Figure 11 Europe Nerve Repair By Biomaterials Market, By Geography, 2013–2019 (USD MN)
Figure 12 Europe Nerve Repair By Neurostimulation  Market , By Geography, 2013–2019 (USD MN)
Figure 13 European Nerve Repair and Regeneration  Market: Growth Analysis, By Geography, 2013-2019 (USD MN)
Figure 14 German Nerve Repair and Regeneration, 2014 & 2019 (%)
Figure 15 German Nerve Repair and Regeneration, By Type, 2013 - 2019 (USD MN)
Figure 16 German Nerve Repair and Regeneration Market Share, By Type, 2014-2019 (%)
Figure 17 France Nerve Repair and Regeneration Market  Overview, 2013 & 2018 (%)
Figure 18 France Nerve Repair and Regeneration  Market, By Type, 2013 – 2019 (USD MN)
Figure 19 France Nerve Repair and Regeneration  Market Share, By Type, 2013-2018 (%)
Figure 20 UK Nerve Repair and Regeneration Market Overview, 2014 & 2019 (%)
Figure 21 UK Nerve Repair and Regeneration Market, By Type , 2013 - 2019 (USD MN)
Figure 22 UK Nerve Repair and Regeneration Market: Type Snapshot
Figure 23 Italy Nerve Repair and Regeneration Market Overview, 2014 & 2019 (%)
Figure 24 UK Nerve Repair and Regeneration Market, By Type , 2013 - 2019 (USD MN)
Figure 25 Italy Nerve Repair and Regeneration Market: Type Snapshot
Figure 26 Spain  Nerve Repair and Regeneration Market Overview, 2014 & 2019 (%)
Figure 27 Spain Nerve Repair and Regeneration Market, By Type , 2013 - 2019 (USD MN)
Figure 28 Italy Nerve Repair and Regeneration Market: Type Snapshot
Figure 29 ROE  Nerve Repair and Regeneration Market Overview, 2014 & 2019 (%)
Figure 30 ROE Nerve Repair and Regeneration Market, By Type , 2013 - 2019 (USD MN)
Figure 31 Italy Nerve Repair and Regeneration Market: Type Snapshot
Figure 32 Nerve Repair and Regenartation Market: Company Share Analysis, 2013 (%)
Figure 33 Nerve Repair and Regeneration Market: Company Product Coverage,  By Type, 2013
Figure 34 Integra Lifesciences Holdings Corp .: Reveue Mix, 2013 (%)
Figure 35 Contribution of Nuerosurgery Segment Towards Company Revenues, 2008-2013 (USD MN)
Figure 36 Stryker  Corporation  Revenue Mix, 2013 (%)
Figure 37 S.T Jude Medical ,Revenue Mix, 2013 (%)
Figure 38 Medtronic, Inc : Revenue Mix 2013 (%)

Nerve repair and regeneration is a procedure that is conducted to repair damaged nerves. Nerve generation is a challenging procedure among all neurological procedures and may be conducted due to loss of functioning of any body parts. This procedure involves using complex surgeries and sub-surgeries. 

The European nerve repair and regeneration market was valued at $1,443.5 million in 2014 and is projected to reach $2,563.9 million by 2019 at a CAGR of 11.9% during the forecast period. The market was led by nerve repair by neurostimulation in 2014, with a share of 66.4%. The nerve repair by neurostimulation market is estimated to grow at the highest CAGR of 11.5% through 2019. Germany is a key market for nerve repair and regeneration in the European region.

The growth of the nerve repair and regeneration market has been rapid in all the countries. This is due to the constantly rising surgeries that pertain to nerves and a high amount of chronic neurological disorders such as epilepsy, Parkinson’s, and Alzheimer’s chronic pain.

The European nerve repair and regeneration market constitutes 28.6% of the global nerve repair and regeneration market and is projected to grow its market share to 11.9% by the end of 2019.

Neurological disorders increased significantly from 4.2% in the 1990s to 6.3% in 2005, contributing to the global burden of diseases, which is expected to reach 6.8% by 2030. The mortality rates are expected to increase to 12.2% by 2030 from 11.7% in 2005. As per the International Federation of Pharmaceutical Manufacturers and Associations, the global burden of mental and neurological disorders is 13% and its total contribution towards non-communicable diseases was estimated to be 30% in 2012.

The incidence of Alzheimer’s was estimated to be 411,000 in 2000, which was expected to increase to 454,000 in 2010; it is further expected to increase to 615,000 by 2030 and 959,000 by 2050. These high incidence rates in neurological disorders will positively affect the market.